|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181 JPY | +2.84% |
|
+1.12% | -4.74% |
| 2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
| 2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
NanoCarrier Co., Ltd. reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was JPY 91 million. Net loss was JPY 887 million.
Basic loss per share from continuing operations was JPY 12.66.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.74% | 79.06M | |
| -2.63% | 102B | |
| +1.62% | 96.29B | |
| +2.62% | 22.18B | |
| -16.67% | 21.2B | |
| -9.16% | 18.31B | |
| -38.74% | 17.38B | |
| -13.21% | 16.36B | |
| +5.41% | 13.97B | |
| +33.57% | 12.17B |
NANO MRNA CO.,LTD. 
